# Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism

> **NCT02677051** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 48 (actual)

## Conditions studied

- Autism
- Autistic Disorder
- Autism Spectrum Disorder
- Autistic Behavior

## Interventions

- **DRUG:** Sulforaphane
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02677051
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-02
- **Primary completion:** 2025-12
- **Final completion:** 2026-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677051, "Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02677051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*